ArticleVaccines2024

Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1.

Jennifer L Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.